Advertisement

Journal of Clinical Immunology

, Volume 7, Issue 4, pp 333–340 | Cite as

Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin

  • Bruce J. Averbook
  • Robert S. Yamamoto
  • Thomas R. Ulich
  • E. W. B. Jeffes
  • Irene Masunaka
  • Gale A. Granger
Original Articles

Abstract

These studies report findings that demonstrate that human alpha lymphotoxin (LT) induces local, visible, and microscopic inflammatory reactions in normal skin. Skin sites in rabbits, when inoculated with a single injection of native or recombinant human alpha lymphotoxin, demonstrated erythema, swelling, and warmth within 5 hr. Erythema peaked between 24 and 48 hr and resolved by 72 hr. Histologic studies of skin sites injected with native LT revealed polymorphonuclear neutrophil (PMN) infiltration and edema beginning as early as 3 hr posttreatment. Individual skin sites that received three daily injections of native LT exhibited persistent erythema and swelling. Palpable induration was evident 24 hr after the second injection in the series. Histologic examination revealed the presence of many PMNs with associated focal dermal destruction, in the form of microabscesses, and scattered mononuclear cells. In contrast, control materials and recombinant human tumor necrosis factor (TNF-alpha) did not induce visible skin reactions in the rabbit. Several additional controls excluded endotoxin as being the agent responsible for the inflammatory skin reactions observed. The ability of LT to induce inflammation may have a role in its antitumor activity and it may be an important endogenous mediator in other immunologic reactions.

Key words

Lymphotoxin tumor necrosis factor inflammation skin reactive factor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Devlin JJ, Klostergard J, Yamamoto RS, Granger GA: Lymphotoxins: After fifteen years of research.In Lymphokines: A Forum for Immunoregulatory Cell Products, E Pick (ed). San Diego, Academic Press, 1982, pp 313–336Google Scholar
  2. 2.
    Granger GA, Williams TW: Lymphocyte cytotoxicityin vitro: Activation and release of a cytotoxic factor. Nature 218:1253–1254, 1968Google Scholar
  3. 3.
    Gray PW, Aggarwal B, Benton C, Bringman T, Henzel W, Jarrett J, Lung D, Moffat B, Ng P, Sevedersky L, Palladino M, Nedwin G: Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312:721–724, 1984Google Scholar
  4. 4.
    Wang A, Creasey A, Ladner M, Lin L, Strickler J, Van Aresdell J, Yamamoto R, Mark D: Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149–154, 1985Google Scholar
  5. 5.
    Orr SL, Plunkett M, Masunaka I, Granger GA: Purification and peptide characterization of human alpha-lymphotoxin obtained from the continuous human lymphoblastoid cell line IR 3.4.In Cellular and Molecular Biology of Lymphokines, C Sorg, A Schimpl (eds). Orlando, FL, Academic Press, 1985, pp 555–559Google Scholar
  6. 6.
    Willoughby DA, Boughton B, Schild HO: A factor capable of increasing vascular permeability present in lymph node cells. Immunology 6:484–498, 1963Google Scholar
  7. 7.
    Bennett B, Bloom R: Reactionsin vivo andin vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci USA 59:756–762, 1968Google Scholar
  8. 8.
    Willoughby DA, Walters MNI, Spector WG: Lymph node permeability factor in dinitrochlorobenzene skin hypersensitivity reaction in guinea-pigs. Immunology 8:578–584, 1965Google Scholar
  9. 9.
    Schwartz HJ, Leon MA, Pelley RP: Concanavalin A-induced release of skin-reactive factor from lymphoid cells. J Immunol 101(1):265–268, 1970Google Scholar
  10. 10.
    Pick E, Krejci J, Turk JL: Release of skin reactive factor from guinea-pig lymphocytes by mitogens. Nature 225:236–238, 1970Google Scholar
  11. 11.
    Houck JC, Barrantes D, Irausquin H: Skin reactive factor and lymph node permeability factor. Agents Actions 3(5):278–283, 1973Google Scholar
  12. 12.
    Spirer Z, Rudich A, Assif E, Zakut V, Bogair N: Release of skin reactive factor by human lymphocytes. Int Arch Allergy Appl Immunol 46:331–338, 1974Google Scholar
  13. 13.
    Houck J, Hellman KB, Chang CM: The biochemistry of lymphocyte-derived mediators of immunological inflammation. Agents Actions 8(1–2):73–79, 1978Google Scholar
  14. 14.
    Averbook B, Yamamoto R, Masunaka I, Orr S, Granger G: Human alpha lymphotoxin: pharmacokinetics and effects on Meth A tumors in BALB/c mice. Fed Proc 45(3):271 (abstr 682), 1986Google Scholar
  15. 15.
    Yamamoto RS, Kobayashi M, Plunkett JM, Masunaka IK, Orr SL, Granger G: Production and detection of lymphotoxinin vitro: micro-assay for lymphotoxin.In Practical Methods in Clinical Immunology, T Yoshida (ed). New York, Churchill Livingstone, 1986, pp 126–133Google Scholar
  16. 16.
    Klostergard J, Granger GA: Human lymphotoxins: Purification to electrophoretic homogeneity of the alpha heavy receptor bearing class. Mol Immunol 18:455–458, 1981Google Scholar
  17. 17.
    Shalaby MR,et al. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 135(3):2069–2073, 1985Google Scholar
  18. 18.
    Pennica D,et al. Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724–728, 1984Google Scholar
  19. 19.
    Aggarwal BB, Henzel WJ, Moffat B, Kohr WJ, Harkins RN: Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J Biol Chem 260(4):2334–2344, 1985Google Scholar
  20. 20.
    Aggarwal BB, Eessalu TE, Hass PE: Characterization of receptors for human tumour necrosis factor and their regulation by gamma interferon. Nature 318(19):665–667, 1985Google Scholar
  21. 21.
    Yamamoto RS, Ware CF, Granger GA: The human LT system. XI. Identification of LT and TNF-like LT forms from stimulated natural killers, specific and nonspecific cytotoxic human T cellsin vitro. J Immunol 137(6):1878–1884, 1986Google Scholar
  22. 22.
    Yamamoto RS, Johnson D, Masunaka I, Granger GA: Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell linesin vitro. J Biol Response Modif 3:76–87, 1983Google Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • Bruce J. Averbook
    • 2
  • Robert S. Yamamoto
    • 1
  • Thomas R. Ulich
    • 3
  • E. W. B. Jeffes
    • 4
  • Irene Masunaka
    • 1
  • Gale A. Granger
    • 1
  1. 1.Department of Molecular Biology and BiochemistryUniversity of California, IrvineIrvine
  2. 2.Department of SurgeryUniversity of California, IrvineIrvine
  3. 3.Department of PathologyUniversity of California, IrvineIrvine
  4. 4.Department of DermatologyUniversity of California, IrvineIrvine

Personalised recommendations